Search results for "Highlights"


 
Results 231 - 240 of about 379 for "Highlights".
Sort by: Relevance | Newest | Oldest

Thiazolidinedione add-ons associated with less CV risk, study finds

The U.K.-based retrospective cohort study used a database that linked national hospitalization and mortality data for people who were prescribed second-line regimens after metformin.
https://diabetes.acponline.org/archives/2016/07/15/2.htm
15 Jul 2016

Intensive glycemic treatment may be common, doubles risk of hypoglycemia

Intensive treatment was defined as use of more glucose-lowering medications than recommended by practice guidelines and was found in 18.7% of clinically complex Medicare patients.
https://diabetes.acponline.org/archives/2016/06/10/2.htm
10 Jun 2016

Excess mortality examined in older patients with diabetes

Excess mortality associated with diabetes was highest in patients younger than age 75 who had had diabetes for a longer time period, with the relative hazard highest in women, a study found.
https://diabetes.acponline.org/archives/2016/06/10/3.htm
10 Jun 2016

Adding DPP-4s to sulfonylureas may increase hypoglycemia risk

The review of 10 randomized controlled trials found 1 excess case of hypoglycemia for every 17 patients in the first 6 months of combined treatment.
https://diabetes.acponline.org/archives/2016/05/13/2.htm
13 May 2016

1-hour glucose value may predict mortality risk

A 1-hour glucose value above 155 mg/dL predicted mortality even when the 2-hour glucose value was below 140 mg/dL, according to the 33-year study.
https://diabetes.acponline.org/archives/2016/05/13/3.htm
13 May 2016

Basal-bolus insulin may require fewer increases in daily doses than other insulin regimens

An observational trial compared insulin glargine once daily, biphasic insulin twice daily, and biphasic insulin three times daily with a basal-bolus regimen of rapid-acting insulin analogue three times daily and long-acting insulin once daily.
https://diabetes.acponline.org/archives/2017/06/09/1.htm
9 Jun 2017

ADA position statement updates recommendations for diabetic retinopathy

The position statement, an update of one from 2002, outlines the stages of diabetic retinopathy and highlights recommendations on optimal blood glycemic control and lowering blood pressure.
https://diabetes.acponline.org/archives/2017/03/10/1.htm
10 Mar 2017

Macular edema, cardiovascular disease associated in type 2 diabetes

Patients with diabetic macular edema or proliferative diabetic retinopathy should be followed more actively to prevent cardiovascular disease, study authors said.
https://diabetes.acponline.org/archives/2017/05/12/1.htm
12 May 2017

Pioglitazone, but not rosiglitazone, associated with increased risk of bladder cancer

The results of this study pose the question of whether the increased likelihood of bladder cancer, which is rare, justifies withholding pioglitazone from adults with type 2 diabetes, according to an accompanying editorial.
https://diabetes.acponline.org/archives/2016/04/08/2.htm
8 Apr 2016

Incretin-based drugs not associated with greater heart failure hospitalization risk than other drug combos in retrospective study

Researchers compared patients taking dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues to those taking 2 or more oral antidiabetic drugs.
https://diabetes.acponline.org/archives/2016/04/08/3.htm
8 Apr 2016

Result Page: Prev   19   20   21   22   23   24   25   26   27   28   Next